-
2
-
-
0242659142
-
Attributable mortality of nosocomial candidemia, revisited
-
Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D. 2003. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 37:1172-1177.
-
(2003)
Clin. Infect. Dis.
, vol.37
, pp. 1172-1177
-
-
Gudlaugsson, O.1
Gillespie, S.2
Lee, K.3
Vande Berg, J.4
Hu, J.5
Messer, S.6
Herwaldt, L.7
Pfaller, M.8
Diekema, D.9
-
3
-
-
0036228505
-
Biofilms: Survival mechanisms of clinically relevant microorganisms
-
Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
-
(2002)
Clin. Microbiol. Rev.
, vol.15
, pp. 167-193
-
-
Donlan, R.M.1
Costerton, J.W.2
-
4
-
-
0037230342
-
Candida biofilms and their role in infection
-
Douglas LJ. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.
-
(2003)
Trends Microbiol.
, vol.11
, pp. 30-36
-
-
Douglas, L.J.1
-
6
-
-
33749986341
-
Candida biofilms on implanted biomaterials: A clinically significant problem
-
Ramage G, Martinez JP, Lopez-Ribot JL. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 6:979-986.
-
(2006)
FEMS Yeast Res.
, vol.6
, pp. 979-986
-
-
Ramage, G.1
Martinez, J.P.2
Lopez-Ribot, J.L.3
-
10
-
-
0035431077
-
Biofilms of Candida albicans and their associated resistance to antifungal agents
-
Ramage G, Wickes BL, Lopez-Ribot JL. 2001. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am. Clin. Lab. 20:42-44.
-
(2001)
Am. Clin. Lab.
, vol.20
, pp. 42-44
-
-
Ramage, G.1
Wickes, B.L.2
Lopez-Ribot, J.L.3
-
11
-
-
0036096359
-
Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins
-
Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 1773-1780
-
-
Kuhn, D.M.1
George, T.2
Chandra, J.3
Mukherjee, P.K.4
Ghannoum, M.A.5
-
12
-
-
67650407551
-
Outcome of antimicrobial therapy in documented biofilm-associated infections: A review of the available clinical evidence
-
Falagas ME, Kapaskelis AM, Kouranos VD, Kakisi OK, Athanassa Z, Karageorgopoulos DE. 2009. Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs 69:1351-1361.
-
(2009)
Drugs
, vol.69
, pp. 1351-1361
-
-
Falagas, M.E.1
Kapaskelis, A.M.2
Kouranos, V.D.3
Kakisi, O.K.4
Athanassa, Z.5
Karageorgopoulos, D.E.6
-
13
-
-
84855683118
-
Antifungal resistance and new strategies to control fungal infections
-
Vandeputte P, Ferrari S, Coste AT. 2012. Antifungal resistance and new strategies to control fungal infections. Int. J. Microbiol. 2012:1-26.
-
(2012)
Int. J. Microbiol.
, vol.2012
, pp. 1-26
-
-
Vandeputte, P.1
Ferrari, S.2
Coste, A.T.3
-
15
-
-
77954340744
-
FDA regulations for drug development
-
doi:10.1126/science.329.5987.33-b
-
Behrman RE, Woodcock J. 2010. FDA regulations for drug development. Science 329:33. doi:10.1126/science.329.5987.33-b.
-
(2010)
Science
, vol.329
, pp. 33
-
-
Behrman, R.E.1
Woodcock, J.2
-
16
-
-
0021742042
-
Isolation of the Candida albicans gene for orotidine-5=-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations
-
Gillum AM, Tsay EY, Kirsch DR. 1984. Isolation of the Candida albicans gene for orotidine-5=-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182.
-
(1984)
Mol. Gen. Genet.
, vol.198
, pp. 179-182
-
-
Gillum, A.M.1
Tsay, E.Y.2
Kirsch, D.R.3
-
17
-
-
51649130981
-
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing
-
Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Jr, Mowat E, Ramage G, Lopez-Ribot JL. 2008. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 3:1494-1500.
-
(2008)
Nat. Protoc.
, vol.3
, pp. 1494-1500
-
-
Pierce, C.G.1
Uppuluri, P.2
Tristan, A.R.3
Wormley Jr., F.L.4
Mowat, E.5
Ramage, G.6
Lopez-Ribot, J.L.7
-
18
-
-
60649094307
-
Effect of tunicamycin on Candida albicans biofilm formation and maintenance
-
Pierce CG, Thomas DP, Lopez-Ribot JL. 2009. Effect of tunicamycin on Candida albicans biofilm formation and maintenance. J. Antimicrob. Chemother. 63:473-479.
-
(2009)
J. Antimicrob. Chemother.
, vol.63
, pp. 473-479
-
-
Pierce, C.G.1
Thomas, D.P.2
Lopez-Ribot, J.L.3
-
21
-
-
0023760272
-
Overview of medically important antifungal azole derivatives
-
Fromtling RA. 1988. Overview of medically important antifungal azole derivatives. Clin. Microbiol. Rev. 1:187-217.
-
(1988)
Clin. Microbiol. Rev.
, vol.1
, pp. 187-217
-
-
Fromtling, R.A.1
-
23
-
-
70350557500
-
Our current understanding of fungal biofilms
-
Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot JL. 2009. Our current understanding of fungal biofilms. Crit. Rev. Microbiol. 35:340-355.
-
(2009)
Crit. Rev. Microbiol.
, vol.35
, pp. 340-355
-
-
Ramage, G.1
Mowat, E.2
Jones, B.3
Williams, C.4
Lopez-Ribot, J.L.5
-
24
-
-
77955355113
-
Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene
-
Nett JE, Crawford K, Marchillo K, Andes DR. 2010. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob. Agents Chemother. 54:3505-3508.
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 3505-3508
-
-
Nett, J.E.1
Crawford, K.2
Marchillo, K.3
Andes, D.R.4
-
25
-
-
70350787156
-
Amphotericin B and its new derivatives-mode of action
-
Baginski M, Czub J. 2009. Amphotericin B and its new derivatives-mode of action. Curr. Drug Metab. 10:459-469.
-
(2009)
Curr. Drug Metab.
, vol.10
, pp. 459-469
-
-
Baginski, M.1
Czub, J.2
-
27
-
-
0036840519
-
In vitro activity of caspofungin against Candida albicans biofilms
-
Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR, Lopez-Ribot JL. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46:3591-3596.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 3591-3596
-
-
Bachmann, S.P.1
Vandewalle, K.2
Ramage, G.3
Patterson, T.F.4
Wickes, B.L.5
Graybill, J.R.6
Lopez-Ribot, J.L.7
-
28
-
-
84858968929
-
Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p)
-
Chan CY, Prudom C, Raines SM, Charkhzarrin S, Melman SD, De Haro LP, Allen C, Lee SA, Sklar LA, Parra KJ. 2012. Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p). J. Biol. Chem. 287:10236-10250.
-
(2012)
J. Biol. Chem.
, vol.287
, pp. 10236-10250
-
-
Chan, C.Y.1
Prudom, C.2
Raines, S.M.3
Charkhzarrin, S.4
Melman, S.D.5
De Haro, L.P.6
Allen, C.7
Lee, S.A.8
Sklar, L.A.9
Parra, K.J.10
-
29
-
-
52949098031
-
Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics
-
Zorko M, Jerala R. 2008. Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics. J. Antimicrob. Chemother. 62:730-737.
-
(2008)
J. Antimicrob. Chemother.
, vol.62
, pp. 730-737
-
-
Zorko, M.1
Jerala, R.2
-
30
-
-
0022372175
-
Final report on the safety assessment of benzethonium chloride and methylbenzethonium chloride
-
Journal Of Toxicology I
-
International Journal of Toxicology 1985. Final report on the safety assessment of benzethonium chloride and methylbenzethonium chloride. Intl. J. Toxicol. 4:65-106.
-
(1985)
Intl. J. Toxicol.
, vol.4
, pp. 65-106
-
-
-
31
-
-
36749095785
-
A review of thimerosal (merthiolate) and its ethylmercury breakdown product: Specific historical considerations regarding safety and effectiveness
-
Geier DA, Sykes LK, Geier MR. 2007. A review of thimerosal (merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. J. Toxicol. Environ. Health B Crit. Rev. 10:575-596.
-
(2007)
J. Toxicol. Environ. Health B Crit. Rev.
, vol.10
, pp. 575-596
-
-
Geier, D.A.1
Sykes, L.K.2
Geier, M.R.3
-
32
-
-
3342969325
-
Prediction of mechanisms of action of antibacterial compounds by gene expression profiling
-
Hutter B, Schaab C, Albrecht S, Borgmann M, Brunner NA, Freiberg C, Ziegelbauer K, Rock CO, Ivanov I, Loferer H. 2004. Prediction of mechanisms of action of antibacterial compounds by gene expression profiling. Antimicrob. Agents Chemother. 48:2838-2844.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 2838-2844
-
-
Hutter, B.1
Schaab, C.2
Albrecht, S.3
Borgmann, M.4
Brunner, N.A.5
Freiberg, C.6
Ziegelbauer, K.7
Rock, C.O.8
Ivanov, I.9
Loferer, H.10
-
34
-
-
0038147060
-
Gold compound auranofin inhibits IB kinase (IKK) by modifying Cys-179 of IKK subunit
-
Jeon KI, Byun MS, Jue DM. 2003. Gold compound auranofin inhibits IB kinase (IKK) by modifying Cys-179 of IKK subunit. Exp. Mol. Med. 35:61-66.
-
(2003)
Exp. Mol. Med.
, vol.35
, pp. 61-66
-
-
Jeon, K.I.1
Byun, M.S.2
Jue, D.M.3
-
35
-
-
84862015314
-
A highthroughput drug screen for Entamoeba histolytica identifies a new lead and target
-
Debnath A, Parsonage D, Andrade RM, He C, Cobo ER, Hirata K, Chen S, Garcia-Rivera G, Orozco E, Martinez MB, Gunatilleke SS, Barrios AM, Arkin MR, Poole LB, McKerrow JH, Reed SL. 2012. A highthroughput drug screen for Entamoeba histolytica identifies a new lead and target. Nat. Med. 19:956-960.
-
(2012)
Nat. Med.
, vol.19
, pp. 956-960
-
-
Debnath, A.1
Parsonage, D.2
Andrade, R.M.3
He, C.4
Cobo, E.R.5
Hirata, K.6
Chen, S.7
Garcia-Rivera, G.8
Orozco, E.9
Martinez, M.B.10
Gunatilleke, S.S.11
Barrios, A.M.12
Arkin, M.R.13
Poole, L.B.14
McKerrow, J.H.15
Reed, S.L.16
-
36
-
-
28144462450
-
Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone
-
Iwanaga T, Kobayashi D, Hirayama M, Maeda T, Tamai I. 2005. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone. Drug Metab. Dispos. 33:1791-1795.
-
(2005)
Drug Metab. Dispos.
, vol.33
, pp. 1791-1795
-
-
Iwanaga, T.1
Kobayashi, D.2
Hirayama, M.3
Maeda, T.4
Tamai, I.5
-
37
-
-
2642518851
-
Quantitative binding models for CYP2C9 based on benzbromarone analogues
-
Locuson CW, II, Rock DA, Jones JP. 2004. Quantitative binding models for CYP2C9 based on benzbromarone analogues. Biochemistry 43:6948-6958.
-
(2004)
Biochemistry
, vol.43
, pp. 6948-6958
-
-
Locuson, C.W.1
Rock, D.A.2
Jones, J.P.3
-
38
-
-
0017342373
-
Anthelmintics
-
Katz M. 1977. Anthelmintics. Drugs 13:124-136.
-
(1977)
Drugs
, vol.13
, pp. 124-136
-
-
Katz, M.1
-
39
-
-
80053460614
-
The effectiveness of two anthelmintics, Vermox (mebendazole) and Povan (pyrvinium pamoate), on Thelastomatid nematodes (Nematoda: Oxyuroidea) of the cockroach, Gromphadorhina portentosa
-
Yu X, Crites JL. 1990. The effectiveness of two anthelmintics, Vermox (mebendazole) and Povan (pyrvinium pamoate), on Thelastomatid nematodes (Nematoda: Oxyuroidea) of the cockroach, Gromphadorhina portentosa. Ohio J. Sci. 90:152-155.
-
(1990)
Ohio J. Sci.
, vol.90
, pp. 152-155
-
-
Yu, X.1
Crites, J.L.2
-
41
-
-
0016631074
-
Mechanisms of anthelmintic action
-
Sheth UK. 1975. Mechanisms of anthelmintic action. Prog. Drug Res. 19:147-157.
-
(1975)
Prog. Drug Res.
, vol.19
, pp. 147-157
-
-
Sheth, U.K.1
-
42
-
-
4544229589
-
Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5- dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation
-
Esumi H, Lu J, Kurashima Y, Hanaoka T. 2004. Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl) ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation. Cancer Sci. 95:685-690.
-
(2004)
Cancer Sci.
, vol.95
, pp. 685-690
-
-
Esumi, H.1
Lu, J.2
Kurashima, Y.3
Hanaoka, T.4
-
43
-
-
0036170245
-
Chemotherapeutic approaches to nematodes: Current knowledge and outlook
-
Harder A. 2002. Chemotherapeutic approaches to nematodes: current knowledge and outlook. Parasitol. Res. 88:272-277.
-
(2002)
Parasitol. Res.
, vol.88
, pp. 272-277
-
-
Harder, A.1
|